Combinations and applications of RAS inhibitors and EGFR inhibitors
TW202633629APending Publication Date: 2026-08-16GUANGZHOU JOYO PHARMATECH CO LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114144343
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-11-06
- Filing Date
- 2025-11-13
- Publication Date
- 2026-08-16
Smart Images
Figure TWG2TA001072997_001 
Figure TWG2TA001072997_002
Abstract
This disclosure relates to a combination of a RAS inhibitor and an EGFR inhibitor and its use therein. Specifically, this disclosure relates to a combination of a RAS inhibitor and an EGFR inhibitor and its use in the treatment of tumors, wherein the RAS inhibitor is compound 1 or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art